T 1545/08 (Combination therapy HCV/MERCK SHARP & DOHME CORP.) of 21.03.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T154508.20120321
- Date of decision
- 21 March 2012
- Case number
- T 1545/08
- Petition for review of
- -
- Application number
- 99303729.0
- IPC class
- A61P 31/14A61K 38/21A61K 31/7056
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having chronic hepatitis C infection
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- Alfa Wassermann S.p.A.
Teva Pharmaceutical Industries Ltd.
Sandoz GmbH
Krauss, Jan B.
Forrester & Boehmert - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(2)European Patent Convention Art 114(2)European Patent Convention Art 56 1973Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Inventive step - (yes)
- Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent as granted.